239 related articles for article (PubMed ID: 11501227)
1. Mealtime glucose regulation in type 2 diabetes.
Tuomilehto J; Del Prato S
Int J Clin Pract; 2001; 55(6):380-3. PubMed ID: 11501227
[TBL] [Abstract][Full Text] [Related]
2. From the control tower: some is better than none and a little bit goes a long way.
Geffner ME
J Pediatr; 2001 Dec; 139(6):766-8. PubMed ID: 11743498
[No Abstract] [Full Text] [Related]
3. Chronic complications of diabetes: a creative management approach.
Eaks GA; Tiszka R
Nurse Pract Forum; 1998 Jun; 9(2):74-86. PubMed ID: 9752122
[TBL] [Abstract][Full Text] [Related]
4. Importance of postprandial glucose control.
Bell DS
South Med J; 2001 Aug; 94(8):804-9. PubMed ID: 11549192
[TBL] [Abstract][Full Text] [Related]
5. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
Unger J; Nadeau DA
J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
[TBL] [Abstract][Full Text] [Related]
6. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
Campbell IW
Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
[TBL] [Abstract][Full Text] [Related]
7. The costs of helping patients with type 1 diabetes achieve tight control.
Nuovo J; Nuovo J
Am Fam Physician; 1999 Nov; 60(7):1914, 1920-1. PubMed ID: 10569496
[No Abstract] [Full Text] [Related]
8. [Therapeutic strategies in type 2 diabetes].
Waeber G; Vollenweider P; Ruiz J
Praxis (Bern 1994); 2001 Dec; 90(51-52):2245-54. PubMed ID: 11820166
[TBL] [Abstract][Full Text] [Related]
9. Advances in therapy for insulin-dependent diabetes mellitus.
Mintz DH
Med Sect Proc; 1993; ():157-69. PubMed ID: 8078868
[No Abstract] [Full Text] [Related]
10. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
Robertson C
Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
Yki-Järvinen H
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
[TBL] [Abstract][Full Text] [Related]
12. Prevention of the complications of diabetes.
Flint MA; Clements RS
Prim Care; 1988 Jun; 15(2):277-84. PubMed ID: 3290919
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
14. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
Winkler G; Baranyi E
Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes mellitus: prevention of macrovascular complications.
Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
[TBL] [Abstract][Full Text] [Related]
16. Controlled drug delivery in the treatment of diabetes mellitus.
Irsigler K; Kritz H; Lovett RG
Crit Rev Ther Drug Carrier Syst; 1985; 1(3):189-280. PubMed ID: 3912064
[TBL] [Abstract][Full Text] [Related]
17. 30 things you should know about managing diabetes.
Bunker K
Diabetes Forecast; 2008 Apr; 61(4):54-6. PubMed ID: 18478645
[No Abstract] [Full Text] [Related]
18. Plasma glucose excursions in older persons with Type 2 diabetes mellitus.
Abbatecola AM; Paolisso G
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):105-7. PubMed ID: 16760636
[TBL] [Abstract][Full Text] [Related]
19. Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice.
Boutati EI; Raptis SA
Diabetes Metab Res Rev; 2004; 20 Suppl 2():S13-23. PubMed ID: 15551342
[TBL] [Abstract][Full Text] [Related]
20. Diabetes complications. Proactive care a must.
Mayo Clin Health Lett; 2012 Oct; 30(10):4-5. PubMed ID: 23133856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
